159 related articles for article (PubMed ID: 26105712)
1. Selenorhodamine photosensitizers with the Texas-red core for photodynamic therapy of cancer cells.
Kryman MW; Davies KS; Linder MK; Ohulchanskyy TY; Detty MR
Bioorg Med Chem; 2015 Aug; 23(15):4501-4507. PubMed ID: 26105712
[TBL] [Abstract][Full Text] [Related]
2. Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.
Hill JE; Linder MK; Davies KS; Sawada GA; Morgan J; Ohulchanskyy TY; Detty MR
J Med Chem; 2014 Oct; 57(20):8622-34. PubMed ID: 25250825
[TBL] [Abstract][Full Text] [Related]
3. Extended rhodamine photosensitizers for photodynamic therapy of cancer cells.
Davies KS; Linder MK; Kryman MW; Detty MR
Bioorg Med Chem; 2016 Sep; 24(17):3908-3917. PubMed ID: 27246858
[TBL] [Abstract][Full Text] [Related]
4. Selective photodepletion of malignant T cells in extracorporeal photopheresis with selenorhodamine photosensitizers.
McIver ZA; Kryman MW; Choi Y; Coe BN; Schamerhorn GA; Linder MK; Davies KS; Hill JE; Sawada GA; Grayson JM; Detty MR
Bioorg Med Chem; 2016 Sep; 24(17):3918-3931. PubMed ID: 27301678
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro biological evaluation of lipophilic cation conjugated photosensitizers for targeting mitochondria.
Rajaputra P; Nkepang G; Watley R; You Y
Bioorg Med Chem; 2013 Jan; 21(2):379-87. PubMed ID: 23245573
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of delocalized lipophilic cationic dyes as delivery vehicles for photosensitizers to mitochondria.
Ngen EJ; Rajaputra P; You Y
Bioorg Med Chem; 2009 Sep; 17(18):6631-40. PubMed ID: 19692249
[TBL] [Abstract][Full Text] [Related]
7. Versatile Strategy To Generate a Rhodamine Triplet State as Mitochondria-Targeting Visible-Light Photosensitizers for Efficient Photodynamic Therapy.
Liu C; Zhou L; Wei F; Li L; Zhao S; Gong P; Cai L; Wong KM
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8797-8806. PubMed ID: 30730131
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-activated nanosystems with selenophenol substituted BODIPYs as photosensitizers for photodynamic therapy.
Gao W; Li M; Xu G; Wang R; Shi B; Zhu T; Gao J; Gu X; Shi P; Zhao C
Bioorg Med Chem Lett; 2020 Jan; 30(2):126854. PubMed ID: 31859157
[TBL] [Abstract][Full Text] [Related]
9. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives.
You Y; Gibson SL; Hilf R; Davies SR; Oseroff AR; Roy I; Ohulchanskyy TY; Bergey EJ; Detty MR
J Med Chem; 2003 Aug; 46(17):3734-47. PubMed ID: 12904078
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers.
Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G
Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422
[TBL] [Abstract][Full Text] [Related]
11. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
12. Dithiaporphyrin derivatives as photosensitizers in membranes and cells.
Minnes R; Weitman H; You Y; Detty MR; Ehrenberg B
J Phys Chem B; 2008 Mar; 112(10):3268-76. PubMed ID: 18278897
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-Targeting Boron Dipyrromethene Based Photosensitizers for Enhanced Photodynamic Therapy: Synthesis, Optical Properties, and in vitro Biological Activity.
Hu P; Weng XL; Zhu CH; Yang DC; Liu JY; Chen Z; Huang M
Chempluschem; 2022 Sep; 87(9):e202200158. PubMed ID: 36148971
[TBL] [Abstract][Full Text] [Related]
14. In vitro demonstration of the heavy-atom effect for photodynamic therapy.
Gorman A; Killoran J; O'Shea C; Kenna T; Gallagher WM; O'Shea DF
J Am Chem Soc; 2004 Sep; 126(34):10619-31. PubMed ID: 15327320
[TBL] [Abstract][Full Text] [Related]
15. Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy.
Costa LD; e Silva Jde A; Fonseca SM; Arranja CT; Urbano AM; Sobral AJ
Molecules; 2016 Mar; 21(4):439. PubMed ID: 27043519
[TBL] [Abstract][Full Text] [Related]
16. Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer.
Nguyen VN; Yan Y; Zhao J; Yoon J
Acc Chem Res; 2021 Jan; 54(1):207-220. PubMed ID: 33289536
[TBL] [Abstract][Full Text] [Related]
17. Theoretical investigation on bisarylselanylbenzo-2,1,3-selenadiazoles as potential photosensitizers in photodynamic therapy.
Mazzone G; De Simone BC; Marino T; Russo N
J Chem Phys; 2021 Feb; 154(8):084113. PubMed ID: 33639755
[TBL] [Abstract][Full Text] [Related]
18. The bromoporphyrins as promising anti-tumor photosensitizers in vitro.
Li MY; Mi L; Namulinda T; Yan YJ; Zhou XP; Chen ZL
Photochem Photobiol Sci; 2023 Feb; 22(2):427-439. PubMed ID: 36344865
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy efficacy enhanced by dynamics: the role of charge transfer and photostability in the selection of photosensitizers.
Arnaut LG; Pereira MM; Dąbrowski JM; Silva EF; Schaberle FA; Abreu AR; Rocha LB; Barsan MM; Urbańska K; Stochel G; Brett CM
Chemistry; 2014 Apr; 20(18):5346-57. PubMed ID: 24644142
[TBL] [Abstract][Full Text] [Related]
20. Polymer-lipid-PEG hybrid nanoparticles as photosensitizer carrier for photodynamic therapy.
Pramual S; Lirdprapamongkol K; Svasti J; Bergkvist M; Jouan-Hureaux V; Arnoux P; Frochot C; Barberi-Heyob M; Niamsiri N
J Photochem Photobiol B; 2017 Aug; 173():12-22. PubMed ID: 28554072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
